Brian Rini, M.D.
| Appointed: |
2005 |
| Gender: |
Male |
| Languages: |
English |
Solid Tumor Oncology
Urology
Biographical Sketch
Brian I. Rini, MD, is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University in Cleveland, Ohio. A Staff member of the Department of Solid Tumor
Oncology and Associate Director for Clinical Research at the Cleveland Clinic Taussig Cancer Institute, Dr.
Rini’s work focuses on genitourinary malignancies.
Dr. Rini earned his medical degree at the Ohio State University College of Medicine in Columbus, Ohio.
After completing a residency program in internal medicine at University of Chicago Hospitals in Illinois,
Dr. Rini was awarded a fellowship in hematology and oncology at the University of Chicago. Dr. Rini was
an Assistant Professor at the University of California San Francisco before moving to Cleveland Clinic.
At Cleveland Clinic, Dr. Rini’s primary research has been in renal cell carcinoma (RCC) and prostate
cancer, with special focus on antiangiogenic therapy and immunotherapy. Dr. Rini’s research has been
published in peer-reviewed journals that include Journal of the National Cancer Institute, Journal of
Clinical Oncology, Cancer, Lancet and JAMA. He is a member of the editorial boards of Journal of Clinical
Oncology, Cancer and British Journal of Urology.
Certified in Medical Oncology by the American Board of Internal Medicine, Dr. Rini is active in numerous
professional organizations, including the American Society of Clinical Oncology (ASCO), American
Association for Cancer Research and the Kidney Cancer Association National Medical Advisory Board. He
serves on the ASCO Board of Experts and on the External Review Board for the ASCO Cancer Therapy
Evaluation Program.
Education & Fellowships
| Medical School: | The Ohio State University College of Medicine and Public Health, Columbus, OH |
|
| Internship: | University of Chicago Hospitals, Internal Medicine, Chicago, IL |
| Residency: | University of Chicago Hospitals, Internal Medicine, Chicago, IL |
| Fellowship: | University of Chicago Hospitals, Hematology / Oncology, Chicago, IL |
| Other Education: | (Undergraduate) University of Notre Dame, Notre Dame, IN |
Certifications
Specialty Interests
Anti-angiogenic therapy, genitourinary oncology, immunotherapy, Prostate Cancer, renal cell carcinoma.
Awards & Honors
Cleveland's Best Doctors, 2005, 2006, 2007
Professional Memberships
- American Society of Clinical Oncology
- American College of Physicians
- American Urological Association
- American Association of Cancer Research
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Rini has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Rini receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Genentech, Inc.
- Novartis
- Pfizer Inc.
- Wyeth Pharmaceuticals Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
